Jul 14, 2025, 00:08

Gilead UK & Ireland Fellowship and Medical Grants Programme – Liver Disease Focus

This strand of Gilead’s UK & Ireland Fellowship and Medical Grants Programme awards one-year grants to healthcare and third-sector organisations pioneering innovation in awareness, diagnosis, and management of liver diseases—particularly viral hepatitis (B, C, delta) and primary biliary cholangitis (PBC). Projects should target improved care pathways, data-driven identification, peer support, and the societal or economic burden of reduced quality of life.

Eligibility Criteria:

Open to healthcare and third-sector organisations based in the UK or Ireland.
Proposals must focus on one or more of the following:
- Awareness and diagnosis of liver diseases (viral hepatitis B/C/delta, PBC).
- Linkage to care and management, including peer support.
- Reducing variations in care and improving experiences for marginalised communities.
- Data-driven diagnosis and re-engagement of those lost to follow-up.
- Quality-of-life research for PBC patients.
- Societal and health-economic studies on the burden of PBC and HDV.
Projects outside these areas—but adding clinical value or addressing unmet needs—may be considered on merit.
Applicants must commit to progress reporting and a final presentation of findings.

Funding Details:

Duration: 1 year (single-cycle grant).
Use of Funds: Project-related expenses (e.g., awareness campaigns, diagnostic tools, peer-support programmes, data-analysis resources, economic evaluations).
Funding Cap: Tailored to project scope; typical grants range up to £50,000, but applicants should propose realistic budgets.

Deadline:

Application window opens April 14, 2025, and closes July 18, 2025.

Where to Go for Further Information:

Submit applications and access full guidelines via the Gilead Sciences UK & Ireland Grants Portal.

For enquiries, email: [email protected].

cancer Gilead Healthcare Innovation HEPATITIS B hepatitis C hepatitis delta Ireland liver disease Medical Grants OncoDaily Oncology primary biliary cholangitis public health UK

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter